Do you have early-stage lung cancer? Were you unable to have surgery or didn't want surgery? If so, you may be able to take part in a clinical trial to find out if adding atezolizumab to radiation is more effective at treating this type of lung cancer.
Do you have triple negative breast cancer? Have you had surgery following chemotherapy? You may be able to participate in a study to find out if stopping pembrolizumab infusions after surgery is just as effective at reducing your risk of cancer recurrence.
Are you between the ages of 40 and 75? Are you willing to give a one-time blood sample? If so, you may be able to take part in a research study that is being used to develop and validate blood tests for early cancer detection.
Are you over 60 and were recently diagnosed with mantle cell lymphoma? You may be able to participate in a research study to determine whether patients who reach complete disease remission after treatment with rituximab and zanubrutinib, will remain longer in remission with or without continuous zanubrutinib treatment.
Help shape the future of lupus! Do you want to provide a game-changing contribution to lupus-centered research? Help us make clinical research more efficient and effective. If you have lupus, you can participate by providing samples we can study, such as blood, urine, saliva, and/or stool, to help doctors combat lupus head-on. Compensation provided.
Are you someone living with Parkinson's disease? If so, you are aware that in addition to symptoms affecting movement, people with Parkinson's disease also experience non-motor symptoms such as problems with mood and motivation which can be difficult to treat. If you have been living with Parkinson's disease for at least 5 years and take medication for Parkinson's disease, you may be eligible to participate in a research study aimed at treating low motivation with a form of non-invasive brain stimulation called transcranial magnetic stimulation (TMS).
Do you have untreated Acute Lymphoblastic Leukemia (ALL) and/or you have relapsed or refractory ALL? You may be able to take part in a research study to help us learn more about the effects of a combination of two drugs on your leukemia.
Have you been diagnosed with Glioblastoma? If so, you may be able to take part in a research study looking at the safety of giving a new drug called IGV-001 to patients with Glioblastoma.
Our team is exploring how technology can help us capture dietary information. We are looking for older adults who will be willing to help us see what is the most effective way to capture nutritional information.
Have you been diagnosed with unfavorable risk prostate cancer? Are you looking for treatment options? If so, you may be able to participate in a clinical trial examining different treatment options for prostate cancer.